Literature DB >> 11515021

Inhibition of transplanted rat tumors by immunization with identical tumor cells infected with Friend virus.

H Kobayashi, F Sendo, H Kaji, T Shirai, H Saito, N Takeichi, M Hosokawa, T Kodama.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 11515021

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  14 in total

1.  Immunogenicity of viable tumor cells. A comparison of xenogenized tumor cells and BCG-tumor cell mixtures.

Authors:  Y Suzuki; K Suzuki; M Hosokawa; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Modification of regression of virally xenogenized tumor cells by cyclophosphamide and busulfan.

Authors:  K Morikawa; J Hamada; T Itaya; M Ishikawa; N Takeichi; M Hosokawa; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

3.  Cytotoxic activity toward mouse melanoma following immunization of mice with transfected cells expressing a human melanoma-associated antigen.

Authors:  J Nowak; E P Cohen; L H Graf
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2.

Authors:  F Okada; M Hosokawa; J Hasegawa; M Ishikawa; I Chiba; Y Nakamura; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  The improved effects of specific active immunotherapy on a rat fibrosarcoma by antitumor drugs.

Authors:  M Komatsumoto; M Hosokawa; F Okada; T Okayasu; T Tanabe; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Induction of high-grade anti-tumor immunity by use of a recombinant H-2Kb/avian erythroblastosis virus erbB gene transfectant.

Authors:  L N Ding; K Isobe; T Yoshida; K Kawashima; I Nakashima
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice.

Authors:  A Vyakarnam; P J Lachmann; K Sikora
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

8.  Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis.

Authors:  A Van Pel; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  Immunity to melanoma in mice immunized with transfected allogeneic mouse fibroblasts expressing melanoma-associated antigens.

Authors:  Y S Kim; R Slomski; E P Cohen
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

10.  Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount anti-tumour responses to PPD-coupled tumour cells.

Authors:  D Y Sia; P J Lachmann; K N Leung
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.